This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Asian Healthcare Specialists Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Belangrijke informatie
28.2%
Groei van de winst
10.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 26.0% |
| Rendement op eigen vermogen | 10.8% |
| Nettomarge | 19.0% |
| Laatste winstupdate | 31 Mar 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Asian Healthcare Specialists geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 22 | 28 | 5 | 0 | 0 |
| 31 Dec 21 | 28 | 5 | 0 | 0 |
| 30 Sep 21 | 28 | 4 | 0 | 0 |
| 30 Jun 21 | 25 | 4 | 0 | 0 |
| 31 Mar 21 | 23 | 4 | 0 | 0 |
| 31 Dec 20 | 20 | 3 | 0 | 0 |
| 30 Sep 20 | 17 | 3 | 0 | 0 |
| 30 Jun 20 | 15 | 3 | 0 | 0 |
| 31 Mar 20 | 13 | 3 | 0 | 0 |
| 31 Dec 19 | 13 | 3 | 0 | 0 |
| 30 Sep 19 | 12 | 3 | 0 | 0 |
| 30 Jun 19 | 12 | 3 | 0 | 0 |
| 31 Mar 19 | 11 | 2 | 0 | 0 |
| 31 Dec 18 | 11 | 2 | 0 | 0 |
| 30 Sep 18 | 11 | 2 | 0 | 0 |
| 30 Jun 18 | 11 | 2 | 0 | 0 |
| 31 Mar 18 | 11 | 2 | 0 | 0 |
| 31 Dec 17 | 11 | 1 | 0 | 0 |
| 30 Sep 17 | 11 | 0 | 0 | 0 |
| 30 Sep 16 | 11 | 2 | 0 | 0 |
Kwaliteitswinsten: 1J3 has high quality earnings.
Groeiende winstmarge: 1J3's current net profit margins (19%) are higher than last year (15.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 1J3's earnings have grown significantly by 28.2% per year over the past 5 years.
Versnelling van de groei: 1J3's earnings growth over the past year (47.9%) exceeds its 5-year average (28.2% per year).
Winst versus industrie: 1J3 earnings growth over the past year (47.9%) exceeded the Healthcare industry 17.8%.
Rendement op eigen vermogen
Hoge ROE: 1J3's Return on Equity (10.8%) is considered low.